An interventional study of VPOD Wireless Tens Unit and Physical Therapy in Ankle Fractures, sponsored by NYU Langone Health. Recruiting at 1 site in United States. Open to participants aged 18 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-02-27.
Sponsored by NYU Langone Health · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 60 studies in Ankle Fractures with a site in United States — 16 open to participants now, 20 under way, none of them phase 3. Ankle Fractures · United States.
Among the 60 studies in Ankle Fractures with a site in United States, this one is the 37th largest by planned enrollment of the 49 interventional ones that give a count, is one of 5 that started in 2025, is one of 37 with no phase, reaches primary completion later than 5 of the 19 other live ones, and was the 54th registered.
203 studies on the registry are indexed under Ankle Fractures; 45 are open to participants now.
Browse Ankle Fractures studies →16 of the 60 studies in Ankle Fractures with a site in United States are open now. Recruiting first, the newest first:
Brian W. Noehren · Sites in United States
Ages 18–50
Jenna-Leigh Wilson · Sites in United States
Ages 18+
University of Kansas Medical Center · Sites in United States
Ages 18+
Maimonides Medical Center · Sites in United States
Ages 22+ · Healthy volunteers
United States Naval Medical Center, San Diego · Sites in United States
Ages 18+
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 31 Ankle Fractures studies recruiting now, 14 (45%) set no upper age limit and 12 (39%) stop at 75 or younger; 4 take children under 18; 3 take healthy volunteers.
This study: 18 Years to 70 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
60 studies; the count open now beside each. This study's row is marked.
First in 1995; this study’s year is marked. 5 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 20 is below the median of 90 across 151 interventional studies indexed under Ankle Fractures.
Median enrollment 55 across the 49 interventional studies, 76 across the 11 observational. Of the 30 that completed or were terminated, 13 (43%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 60 have an industry lead sponsor. The 10 most frequent:
NYU Langone Health is the lead sponsor of 1,431 studies on the registry; 258 are open to participants now.
Of its 235 completed or terminated interventional studies of FDA-regulated products, 197 (84%) have results posted.
NYU Langone Health has 3 studies filed under Ankle Fractures — fewer than ten, so there is no comparison to draw.
12 of the studies in Ankle Fractures with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05280639University of VirginiaSimplified Post Op Rehabilitation for Ankle and Pilon Fractures | 2026-12-01 |
| NCT06370325NYU Langone HealthNeuromuscular Electrical Stimulation in Foot and Ankle Surgery | 2026-12-30 |
| NCT04113044AO Innovation Translation CenterGo Fit Fast, Recovery Trajectory Using PROMIS®, Linking PROMIS® | 2026-12-31 |
| NCT06085586Maimonides Medical CenterFibulink Syndesmosis Repair System With Early Full-Weight Bearing | 2026-12-31 |
| NCT05729542University of California, San DiegoComparing Clinical Outcomes of Suture Button Versus Fibulink Fixation for Acute Ankle Syndesmosis Injuries | 2026-12-31 |
Add all 12 to your calendar (.ics) → With an account.
Among the 60 studies in Ankle Fractures with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This is a pilot randomized controlled trial, wherein the intervention group will undergo NMES five days a week beginning three weeks postoperative and lasting for ten weeks. Both the control and intervention groups will start standard physical therapy six weeks postoperative. Primary outcome measure will be the isometric strength of the gastrocnemius muscle. The secondary outcomes will comprise subjective clinical evaluations (using the Lower Extremity Functional Scale [LEFS]), functional assessments such as the sit-to-stand test, 2-minute walk test, stair climb test and objective clinical evaluation using contralateral comparison of calf circumference.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients with medical histories that include:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Corticosteroids (steroids)
Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.
Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Participants randomized to the intervention group will undergo neuromuscular electrical stimulation (NMES) five days a week beginning three weeks postoperative and lasting for ten weeks. The intervention group will begin standard physical therapy at six weeks postoperative.
Procedure: VPOD Wireless Tens Unit · Procedure: Physical Therapy · Device: Biodex
Participants randomized to the control group will begin standard physical therapy at six weeks postoperative.
Procedure: Physical Therapy · Device: Biodex
The VPOD unit will deliver NMES to participants in the Intervention Group.
Physical therapy as per standard of care.
Used to assess strength, endurance, power, and range of motion.
Isometric Strength of Gastrocnemius Muscle
Measured using Biodex dynamometer.
Time frame: Week 6
Isometric Strength of Gastrocnemius Muscle
Measured using Biodex dynamometer.
Time frame: Week 9
Isometric Strength of Gastrocnemius Muscle
Measured using Biodex dynamometer.
Time frame: Week 12
Bilateral Calf Circumference
Time frame: Week 6
Bilateral Calf Circumference
Time frame: Week 9
Bilateral Calf Circumference
Time frame: Week 12
Lower Extremity Functional Scale (LEFS) Questionnaire Score
LEFS is a 20-item questionnaire assessing functional impairment in patients with disorders affecting one or both lower extremities. Each item is rated on a scale ranging from 0 to 4: 0 indicates inability to perform the activity or extreme difficulty, 1 indicates considerable difficulty, 2 indicates moderate difficulty, 3 indicates slight difficulty, and 4 indicates no difficulty. The score is the sum of responses and ranges from a minimum of 0 to a maximum of 80, with lower scores indicating greater disability.
Time frame: Week 6
Lower Extremity Functional Scale (LEFS) Questionnaire Score
LEFS is a 20-item questionnaire assessing functional impairment in patients with disorders affecting one or both lower extremities. Each item is rated on a scale ranging from 0 to 4: 0 indicates inability to perform the activity or extreme difficulty, 1 indicates considerable difficulty, 2 indicates moderate difficulty, 3 indicates slight difficulty, and 4 indicates no difficulty. The score is the sum of responses and ranges from a minimum of 0 to a maximum of 80, with lower scores indicating greater disability.
Time frame: Week 9
Lower Extremity Functional Scale (LEFS) Questionnaire Score
LEFS is a 20-item questionnaire assessing functional impairment in patients with disorders affecting one or both lower extremities. Each item is rated on a scale ranging from 0 to 4: 0 indicates inability to perform the activity or extreme difficulty, 1 indicates considerable difficulty, 2 indicates moderate difficulty, 3 indicates slight difficulty, and 4 indicates no difficulty. The score is the sum of responses and ranges from a minimum of 0 to a maximum of 80, with lower scores indicating greater disability.
Time frame: Week 12
Sit-to-Stand Test
The sit-to-stand test involves recording the number of stands a person can complete in 30 seconds.
Time frame: Week 6
Sit-to-Stand Test
The sit-to-stand test involves recording the number of stands a person can complete in 30 seconds.
Time frame: Week 9
Sit-to-Stand Test
The sit-to-stand test involves recording the number of stands a person can complete in 30 seconds.
Time frame: Week 12
2 Minute Walk Test
In this activity, the participant is encouraged to walk as fast as they can, safely, without assistance for two minutes and the distance is measured
Time frame: Week 6
2 Minute Walk Test
In this activity, the participant is encouraged to walk as fast as they can, safely, without assistance for two minutes and the distance is measured
Time frame: Week 9
2 Minute Walk Test
In this activity, the participant is encouraged to walk as fast as they can, safely, without assistance for two minutes and the distance is measured
Time frame: Week 12
Stair Climb Test
The stair climb test measures the amount of time a person ascends and descends a flight of stairs, while walking as quickly as they feel safe and comfortable to move.
Time frame: Week 6
Stair Climb Test
The stair climb test measures the amount of time a person ascends and descends a flight of stairs, while walking as quickly as they feel safe and comfortable to move.
Time frame: Week 9
Stair Climb Test
The stair climb test measures the amount of time a person ascends and descends a flight of stairs, while walking as quickly as they feel safe and comfortable to move.
Time frame: Week 12
Plan to share: No — Data to be used only by the research team.
No publications or documents are linked to this record.
Started Jun 2025 (actual). Primary completion is estimated for Dec 2026, 18 months after the start.
Of 69 non-industry interventional studies with no phase under Ankle Fractures, half reached primary completion within 44 months of starting (the median), counting those still running; a quarter within 23 and three quarters within 61. This study's planned 18 months is below that.
Counting every sponsor, half of 72 studies reached it within 45 months; a quarter within 23 and three quarters within 61.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.